These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34405837)

  • 1. Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient.
    Juan-Carpena G; Palazón-Cabanes JC; Bañuls J; Docampo-Simón A; Sánchez-Pujol MJ; Niveiro M; Silvestre JF
    Dermatitis; 2021 Oct; 32(1S):e83-e85. PubMed ID: 34405837
    [No Abstract]   [Full Text] [Related]  

  • 2. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse erythema and peeling during dupilumab therapy in a patient with atopic dermatitis.
    Cheng B; Yin M; Dou X
    Dermatol Ther; 2021 Nov; 34(6):e15183. PubMed ID: 34716650
    [No Abstract]   [Full Text] [Related]  

  • 4. A paradoxical head and neck erythema: an adverse event due to dupilumab in adult patients with atopic dermatitis.
    Russo F; Rizzo A; Santi F; Lamberti A; Lazzeri L; Flori ML; Rubegni P
    Int J Dermatol; 2022 Jun; 61(6):e204-e206. PubMed ID: 34480761
    [No Abstract]   [Full Text] [Related]  

  • 5. Paradoxical Head and Neck Erythema in Patients Treated With Dupilumab: Not Only Red Face.
    Russo F; Sordi D; Madonna S; Dattolo A; Scala E; Pilla MA; Pallotta S; Giampetruzzi AR; De Pità O; Cocuroccia B
    Dermatitis; 2024; 35(4):421-423. PubMed ID: 38484334
    [No Abstract]   [Full Text] [Related]  

  • 6. Facial and neck erythema associated with dupilumab treatment: A systematic review.
    Jo CE; Finstad A; Georgakopoulos JR; Piguet V; Yeung J; Drucker AM
    J Am Acad Dermatol; 2021 May; 84(5):1339-1347. PubMed ID: 33428978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema nodosum of the extremities following dupilumab treatment in a patient with atopic dermatitis.
    Hanami Y; Yamamoto T
    J Dermatol; 2024 Sep; 51(9):e291-e292. PubMed ID: 38587252
    [No Abstract]   [Full Text] [Related]  

  • 8. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
    Ordóñez-Rubiano MF; Casas M; Balaguera-Orjuela V
    Dermatol Ther; 2021 Nov; 34(6):e15140. PubMed ID: 34549488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series.
    Mareschal A; Puzenat E; Aubin F
    Acta Derm Venereol; 2020 Jan; 100(1):adv00014. PubMed ID: 31709451
    [No Abstract]   [Full Text] [Related]  

  • 10. Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: A case report.
    Tsai YC; Tsai TF
    Dermatol Ther; 2022 Nov; 35(11):e15843. PubMed ID: 36124378
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series.
    de Wijs LEM; Nguyen NT; Kunkeler ACM; Nijsten T; Damman J; Hijnen DJ
    Br J Dermatol; 2020 Oct; 183(4):745-749. PubMed ID: 31749159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic annular erythema-like adult-onset atopic dermatitis successfully treated with dupilumab.
    Liaw TY
    Ital J Dermatol Venerol; 2024 Apr; 159(2):203-205. PubMed ID: 38650501
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterizing dupilumab facial redness: A multi-institution retrospective medical record review.
    Waldman RA; DeWane ME; Sloan B; Grant-Kels JM
    J Am Acad Dermatol; 2020 Jan; 82(1):230-232. PubMed ID: 31228530
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab.
    Ferrucci S; Tavecchio S; Berti E; Angileri L
    Clin Exp Dermatol; 2020 Jul; 45(5):625-626. PubMed ID: 32112580
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosacea associated with dupilumab therapy.
    Heibel HD; Hendricks AJ; Foshee JP; Shi VY
    J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythema, pruritus, and diffuse peeling of skin during dupilumab therapy for atopic dermatitis in three adults.
    Al Hammadi A; Parmar NV
    Int J Dermatol; 2019 Jan; 58(1):e14-e15. PubMed ID: 30390308
    [No Abstract]   [Full Text] [Related]  

  • 17. Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology.
    Ahn J; Lee DH; Na CH; Shim DH; Choi YS; Jung HJ; Simpson EL
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2140-2152. PubMed ID: 35695074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angioedema: A potential complication of dupilumab in atopic dermatitis.
    Fritz AL; Lacy FA; Morrell DS
    Pediatr Dermatol; 2021 Jan; 38(1):237-238. PubMed ID: 33099796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of dupilumab in patients with atopic dermatitis: expert opinion.
    Francuzik W; Alexiou A; Worm M
    Expert Opin Drug Saf; 2021 Sep; 20(9):997-1004. PubMed ID: 34114910
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythema induratum of Bazin during successful treatment of atopic dermatitis with dupilumab.
    Zhou C; Su T; Wang Y; Hou Y; Yin Z; Xia J
    Australas J Dermatol; 2024 May; 65(3):e69-e71. PubMed ID: 38421820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.